Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 476

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft

Open access
Mohiuddin, Muhammad M., Singh, Avneesh K., Corcoran, Philip C., Thomas III, Marvin L., Clark, Tannia, Lewis, Billeta G., Hoyt, Robert F., Eckhaus, Michael, Pierson III, Richard N., Belli, Aaron J., Wolf, Eckhard, Klymiuk, Nikolai, Phelps, Carol, Reimann, Keith A., Ayares, David, Horvath, Keith A.·2016·Nature Communications

Abstract

Preventing xenograft rejection is one of the greatest challenges of transplantation medicine. Here, we describe a reproducible, long-term survival of cardiac xenografts from alpha 1-3 galactosyltransferase gene knockout pigs, which express human complement regulatory protein CD46 and human thrombomodulin (GTKO.hCD46.hTBM), that were transplanted into baboons. Our immunomodulatory drug regimen includes induction with anti-thymocyte globulin and αCD20 antibody, followed by maintenance with mycophenolate mofetil and an intensively dosed αCD40 (2C10R4) antibody. Median (298 days) and longest (945 days) graft survival in five consecutive recipients using this regimen is significantly prolonged over our recently established survival benchmarks (180 and 500 days, respectively). Remarkably, the reduction of αCD40 antibody dose on day 100 or after 1 year resulted in recrudescence of anti-pig antibody and graft failure. In conclusion, genetic modifications (GTKO.hCD46.hTBM) combined with the treatment regimen tested here consistently prevent humoral rejection and systemic coagulation pathway dysregulation, sustaining long-term cardiac xenograft survival beyond 900 days.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms11138

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 476

Metadata

Authors
Mohiuddin, M. M., Singh, A. K., Corcoran, P. C., Thomas III, M. L., Clark, T., Lewis, B. G., Hoyt, R. F., Eckhaus, M., Pierson III, R. N., Belli, A. J., Wolf, E., Klymiuk, N., Phelps, C., Reimann, K. A., Ayares, D., & Horvath, K. A.
Venue
Nature Communications
Published
2016-04-05
Volume
7
Issue
1
Pages
11138-11138
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2315479515
Cited by
476
References
24
FWCI
45.47
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. https://app.cochat.ai/papers/10.1038/ncomms11138
The paper
Mohiuddin, M. M., Singh, A. K., Corcoran, P. C., Thomas III, M. L., Clark, T., Lewis, B. G., Hoyt, R. F., Eckhaus, M., Pierson III, R. N., Belli, A. J., Wolf, E., Klymiuk, N., Phelps, C., Reimann, K. A., Ayares, D., & Horvath, K. A. (2016). Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nature Communications. https://doi.org/10.1038/ncomms11138

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.